20-HETE Mimetics or Inhibitors in the Treatment of Cancer Patients with Sepsis and Septic Shock

Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2013, Vol 2, Issue 1

Abstract

Patients with a variety of malignancies have a greater tendency to acquire infections than patients with non-malignant disorders. Sepsis and septic shock are common complications in patients with cancer. As the most common causes of morbidity and mortality in intensive care units worldwide, the societal and economic costs of cancer, sepsis, and septic shock are staggering. The molecular pathophysiology of cancer, sepsis, and septic shock remains controversial despite decades of study. 20Hydroxyeicosatetraenoic acid (20-HETE), a ω-hydroxylation product of arachidonic acid that is produced by cytochrome P450 (CYP) enzymes, mainly by CYP4A and CYP4F isoforms, has been implicated in the regulation of protooncogenic, mitogenic, and angiogenic responses both in vitro and in vivo as well as inflammation that can support tumor progression. Therefore, selective 20-HETE inhibitors has been suggested to be a new class of compounds with antitumor and antiangiogenic activity. On the other hand, studies from our laboratory and others have provided substantial evidence that administration of a synthetic analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, a 20-HETE mimetic, prevents vascular hyporeactivity, hypotension, tachycardia, inflammation, and mortality presumably due to increased CYP4A1 expression and formation of 20-HETE associated with decreased vasodilatory and proinflammatory mediator production in a rodent model of septic shock. This review will focus on the rationale for the use of 20-HETE mimetics or inhibitors for the treatment of cancer patients with sepsis and septic shock

Authors and Affiliations

Tunctan B

Keywords

Related Articles

Incidentally Detected Spindle Cell Tumor on F-18 FDG PET/CT for Staging of Lung Cancer

A 77-year-old male visited the hospital due to dyspnea, cough and sputum production, and a lung mass on chest radiography. F-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) demonstr...

Store-Operated Calcium Channel and Cancer

The increase of intracellular Ca2+ concentration is an important mechanism that regulates a variety of physiological processes ranging from exocytosis to gene regulation and cell proliferation [1]. Calcium release from...

Gastric Cancer with Situs Inversus

A male patient, 71 years old, chronic smoker 30 pack years, has presented four months before his consultation, epigastric pain without vomiting or gastro-intestinal bleeding, evolving in a context of weakness with weight...

An Overview on Oncolytic Viruses as Cancer Therapy

The current regimen of cancer therapy (chemotherapy and radiotherapy) suffers with disadvantages such as narrow therapeutic index that further facilitate tumor evolves drug resistance and severe side-effects. Oncolytic v...

Anticancer Activity of Acetone Extract of Quercus infectoria Olivier Fagaceae in 1,2 Dimethyl Hydrazine Induced Colon Cancer

Quercus infectoria Olivier (Fagaceae) which contains abundant amount of hydrolysable tannins and traces of gallic acid, ellagic acid and sitosterol is reported to be effective in inflammatory bowel disease. In the presen...

Download PDF file
  • EP ID EP197890
  • DOI 10.19070/2167-9118- 130001
  • Views 102
  • Downloads 0

How To Cite

Tunctan B (2013). 20-HETE Mimetics or Inhibitors in the Treatment of Cancer Patients with Sepsis and Septic Shock. International Journal of Cancer Studies & Research (IJCR), 2(1), 1-12. https://europub.co.uk/articles/-A-197890